Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYBiomedicines

Personalized Therapeutic Strategies in Glioblastoma: Bridging Molecular Markers and In Vivo Observations for Targeted Treatment

  • Joaquin Fiallo Arroyo1
  • Jose E. Leon-Rojas1
  1. 1Escuela de Medicina, Universidad de Las América, Quito 170125, Ecuador;
Read full textPDFCite

Related

  1. Frontier therapeutic strategies and molecular mechanisms of glioblastoma (Review).
    Longfei Shao, Shuo Sun, Liling Yang +2
    Molecular and clinical oncologyPeer-reviewedCC BY-NC-NDFull textHuman geneticsEurope PMCPMC
  2. Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation.
    Lukas Gorecki
    Experimental hematology & oncologyPeer-reviewedCC BY-NC-NDFull textHuman geneticsEurope PMCPMC
  3. Glioblastoma stem cell–immune microenvironment crosstalk: molecular mechanisms and therapeutic opportunities
    Chuanhai Xu, Linlin Chai, Wei Yuan
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textHuman geneticsCrossrefEurope PMC
  4. Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies
    Zhiwei Dong, Feibo Xu, Mei Ye +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies
    Chen-xi Zhao, Shu-yun Wang, Ke Li
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text2 citedOncologyPMC

Cite

BibTeXRIS
BibTeX
@article{arroyo2026personalized,
  title = {{Personalized Therapeutic Strategies in Glioblastoma: Bridging Molecular Markers and In Vivo Observations for Targeted Treatment}},
  author = {Joaquin Fiallo Arroyo and Jose E. Leon-Rojas},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701823},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Personalized Therapeutic Strategies in Glioblastoma: Bridging Molecular Markers and In Vivo Observations for Targeted Treatment
AU  - Joaquin Fiallo Arroyo
AU  - Jose E. Leon-Rojas
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701823
SN  - 2227-9059
ER  -